Frontiers in Hypertension Research

[1]  J. O. Davis,et al.  Mechanisms regulating renin release. , 1976, Physiological reviews.

[2]  W. Schoeppe,et al.  Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol). , 1976, Clinical science and molecular medicine. Supplement.

[3]  A. Amery,et al.  Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients. , 1976, American heart journal.

[4]  S. Julius,et al.  SUPPRESSION OF SYMPATHETIC NERVOUS FUNCTION IN LOW-RENIN ESSENTIAL HYPERTENSION , 1976, The Lancet.

[5]  J. Cruickshank,et al.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension. , 1976, British medical journal.

[6]  J. Fray.  Stimulation of renin release in perfused kidney by low calcium and high magnesium. , 1977, The American journal of physiology.

[7]  M. Dubocovich,et al.  STIMULATION OF PRESYNAPTIC β‐ADRENOCEPTORS ENHANCES [3H]‐N0RADRENALINE RELEASE DURING NERVE STIMULATION IN THE PERFUSED CAT SPLEEN , 1978 .

[8]  H. Ibsen,et al.  Plasma volume and extracellular fluid volume during long-term treatment with propranolol in essential hypertension. , 1972, Clinical science.

[9]  D. Young.  Comparison of a Beta-Blocker and Converting Enzyme Inhibitor in Two Types of Experimental Hypertension , 1981 .

[10]  T. Inagami,et al.  Evidence for a completely inactive renin zymogen in the kidney by affinity chromatographic isolation. , 1980, Biochemical and biophysical research communications.

[11]  J. Laragh,et al.  Plasma Prorenin in Normal, Hypertensive, and Anephric Subjects and Its Effect on Renin Measurements , 1977, Circulation research.

[12]  J. Gerber,et al.  Prostaglandins and Renin Release The Effect of PGI2, PGE2, and 13,14‐Dihydro PGE2 on the Baroreceptor Mechanism of Renin Release in the Dog , 1979, Circulation research.

[13]  A. Roach,et al.  CARDIOVASCULAR EFFECTS OF β‐ADRENORECEPTOR BLOCKING AGENTS AFTER INTRACEREBROVENTRICULAR ADMINISTRATION IN CONSCIOUS NORMOTENSIVE CATS , 1974, Clinical and experimental pharmacology & physiology.

[14]  D. Streeten,et al.  Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;. , 1975, The New England journal of medicine.

[15]  L. Klevans,et al.  Central effect of beta adrenergic blocking agents on arterial blood pressure. , 1976, The Journal of pharmacology and experimental therapeutics.

[16]  C. Dollery,et al.  Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit. , 1974, The Journal of pharmacology and experimental therapeutics.

[17]  F. Dunn,et al.  Benzothiadazine diuretics and death from myocardial infarction in hypertension. , 1978, Clinical science and molecular medicine. Supplement.

[18]  J. Tobis,et al.  Antihypertensive and hemodynamic effects of oxprenolol versus propranolol , 1980, Clinical pharmacology and therapeutics.

[19]  R. P. Day,et al.  Properties of inactive renin in human plasma , 1979, Clinical and experimental pharmacology & physiology.

[20]  F. W. Lohmann,et al.  Differential Effects of Long‐Term Cardioselective and Nonselective Beta‐Receptor Blockade on Plasma Catecholamines During and After Physical Exercise in Hypertensive Patients , 1980, Journal of cardiovascular pharmacology.

[21]  H. Waal-Manning.  The antihypertensive action of several beta-adrenoreceptor-blocking drugs. , 1976, The New Zealand medical journal.

[22]  J. Laragh,et al.  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. , 1978, Progress in cardiovascular diseases.

[23]  J. O. Davis,et al.  Renin release from filtering and nonfiltering kidneys stimulated by PGI2 and PGD2. , 1979, The American journal of physiology.

[24]  W. Ganong,et al.  Effect of Theophylline and Adrenergic Blocking Drugs on the Renin Response to Norepinephrine In Vitro , 1974, Circulation research.

[25]  A. Roach,et al.  CENTRAL α‐ AND β‐ADRENOCEPTORS MODIFYING ARTERIAL BLOOD PRESSURE AND HEART RATE IN CONSCIOUS CATS , 1974 .

[26]  N. Winer,et al.  Effects of Cyclic AMP, Sympathomimetic Amines, and Adrenergic Receptor Antagonists on Renin Secretion , 1971, Circulation research.

[27]  P. Wolf,et al.  Hemoglobin and the risk of cerebral infarction: the Framingham Study. , 1972, Stroke.

[28]  A. Shulkes,et al.  The nature of inactive renin in human plasma and amniotic fluid. , 1978, Clinical science and molecular medicine.

[29]  H. L. Garvey,et al.  Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs. , 1975, The Journal of pharmacology and experimental therapeutics.

[30]  M. Vallotton,et al.  Renin Release by Rat Kidney Slices Incubated in Vitro: Role of Sodium and of α ‐ and β ‐Adrenergic Receptors, and Effect of Vincristine , 1976, Circulation research.

[31]  L. Wilhelmsen,et al.  CORONARY HEART-DISEASE AFTER TREATMENT OF HYPERTENSION , 1978, The Lancet.

[32]  N. Christensen,et al.  Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. , 2009, Acta medica Scandinavica.

[33]  T. Berl,et al.  Prostaglandins in the beta-adrenergic and baroreceptor-mediated secretion of renin. , 1979, The American journal of physiology.

[34]  J. Laragh.  The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatment , 1978 .

[35]  M. Kawamura,et al.  High-Molecular-Weight Form of Renal Renin and Renin-Binding Substance in the Dog , 1981 .

[36]  K. Becker,et al.  Evidence for a role of plasma kallikrein in the activation of prorenin , 1980, Nature.

[37]  J. Ménard,et al.  Effect of acid trypsin and cold treatment and of renin--plasma interaction on the activity of renin secreted by rat kidney. , 1979, Clinical science.

[38]  M. Weinberger,et al.  Dynamic Responses of Active and Inactive Renin in Normal and Hypertensive Humans , 1977, Circulation research.

[39]  B. Morris,et al.  THE RENIN-ANGIOTENSI N SYSTEM , 1978 .

[40]  N. Takahashi,et al.  A new form of renin in normal human plasma: "big renin" is a mixture of inactive prorenin and the new active high molecular weight renin. , 1980, Life sciences.

[41]  J. Laragh,et al.  Low and High Renin Essential Hypertension: A Comparison of Clinical and Biochemical Characteristics , 1981, The American journal of the medical sciences.

[42]  M. Chatterjee,et al.  Beta adrenergic blockade in hypertension. , 1976, The Journal of the Association of Physicians of India.

[43]  A. Freedman,et al.  Adrenergic receptor mediation of renin secretion. , 1969, The Journal of clinical endocrinology and metabolism.

[44]  J. Laragh,et al.  PLASMA RENIN AND "PRORENIN" IN ESSENTIAL HYPERTENSION DURING SODIUM DEPLETION, BETA-BLOCKADE, AND REDUCED ARTERIAL PRESSURE , 1977, The Lancet.

[45]  P. Churchill,et al.  Phenytoin stimulates renin secretion from rat kidney slices. , 1979, The Journal of pharmacology and experimental therapeutics.

[46]  J. Laragh,et al.  An inactive, prorenin-like substance in human kidney and plasma. , 1980, Clinical science.

[47]  G. W. Boyd.  AN INACTIVE HIGHER-MOLECULAR-WEIGHT RENIN IN NORMAL SUBJECTS AND HYPERTENSIVE PATIENTS , 1977, The Lancet.

[48]  D. O'Connor,et al.  Renin requires a structural alteration prior to activation by renal kallikrein. , 1980, The Journal of clinical endocrinology and metabolism.

[49]  J. Laragh,et al.  The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. , 1970, The Journal of clinical investigation.

[50]  J. Laragh,et al.  Effect of trypsin or acid treatment on dog plasma renin activity measurements. , 1980, Endocrinology.

[51]  P. Weidmann,et al.  Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. , 1977, The American journal of medicine.

[52]  W. Peart,et al.  CALCIUM DEPENDENCE OF THE INHIBITORY EFFECT OF ANGIOTENSIN ON RENIN SECRETION IN THE ISOLATED PERFUSED KIDNEY OF THE RAT , 1974, British journal of pharmacology.

[53]  J. Ménard,et al.  Pepstatin, an inhibitor for renin purification by affinity chromatography , 1973, FEBS letters.

[54]  J. Laragh,et al.  An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. , 1974, The New England journal of medicine.

[55]  W. Campbell,et al.  Role of renal prostaglandins in sympathetically mediated renin relase in the rat. , 1979, The Journal of clinical investigation.

[56]  R. Tarazi,et al.  Hyperkinetic heart in severe hypertension: a separate clinical hemodynamic entity. , 1975, The American journal of cardiology.

[57]  R. Rubin.  The role of calcium in the release of neurotransmitter substances and hormones. , 1970, Pharmacological reviews.

[58]  C. Pietro,et al.  Two fractions of cryoactivable prorenin in human plasma. , 1979, Biochemical medicine.

[59]  T. Berl,et al.  Mechanisms of renin secretion during hemorrhage in the dog. , 1979, The Journal of clinical investigation.

[60]  P. Lund-johansen,et al.  Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol. , 1976, Clinical science and molecular medicine. Supplement.

[61]  P. Churchill,et al.  Effect of ouabain on renin secretion in anaesthetized dogs , 1974, The Journal of physiology.

[62]  M J Dunn,et al.  Prostaglandins and the kidney. , 1977, The American journal of physiology.

[63]  A. Poisner,et al.  Partial purification and chromatographic properties of inactive renin from human amniotic fluid. , 1979, Biochemical pharmacology.

[64]  R. Russell,et al.  Effect of high haematocrit on alertness. , 1980, Lancet.

[65]  F. Knox,et al.  Dissociation of renin release and renal vasodilation by prostaglandin synthesis inhibitors. , 1979, The American journal of physiology.

[66]  H. Gavras,et al.  Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. , 1979, Annals of internal medicine.

[67]  L. Barajas.  Anatomy of the juxtaglomerular apparatus. , 1979, The American journal of physiology.

[68]  W. Walters,et al.  Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma. , 1975, American journal of obstetrics and gynecology.

[69]  Y. Funae,et al.  Conversion between renin and high-molecular-weight renin in the dog. , 1978, The Biochemical journal.

[70]  A. Loh,et al.  PROTEASE AS ENDOGENOUS ACTIVATOR OF INACTIVE RENIN , 1978, The Lancet.

[71]  A. Schwartz.  Cell membrane Na+, K+-ATPase and sarcoplasmic reticulum: possible regulators of intracellular ion activity. , 1976, Federation proceedings.

[72]  T. Zenser,et al.  Comparison of the effects of prostaglandin I2 and prostaglandin E2 stimulation of the rat kidney adenylate cyclase-cyclic AMP systems. , 1979, Biochimica et biophysica acta.

[73]  J. Laragh,et al.  Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects. , 1976, The American journal of medicine.

[74]  F. Fay,et al.  Mechanism of β- adrenergic relaxation of smooth muscle , 1979, Nature.

[75]  J. Laragh,et al.  Linking the kallikrein and renin systems via activation of inactive renin: new data and a hypothesis. , 1978, The American journal of medicine.